We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTMI icon
1251
TTM Technologies
TTMI
$13.8B
$5.02M 0.01%
333,536
+17,710
+6% +$233K
TSE
1252
DELISTED
Trinseo
TSE
$5.01M 0.01%
134,665
+5,443
+4% +$221K
WTM icon
1253
White Mountains Insurance
WTM
$5.24B
$5.01M 0.01%
4,488
+422
+10% +$460K
GIII icon
1254
G-III Apparel Group
GIII
$1.55B
$5M 0.01%
149,360
+7,859
+6% +$223K
SYKE
1255
DELISTED
SYKES Enterprises Inc
SYKE
$4.98M 0.01%
134,745
+6,483
+5% +$219K
ALEX
1256
DELISTED
Alexander & Baldwin
ALEX
$4.97M 0.01%
237,185
+6,732
+3% +$152K
AUB icon
1257
Atlantic Union Bankshares
AUB
$6.12B
$4.95M 0.01%
131,860
+2,769
+2% +$104K
HLX icon
1258
Helix Energy Solutions
HLX
$1.37B
$4.94M 0.01%
512,559
+26,840
+6% +$232K
EPAC icon
1259
Enerpac Tool Group
EPAC
$1.9B
$4.93M 0.01%
189,261
+8,741
+5% +$213K
NTNX icon
1260
Nutanix
NTNX
$16.3B
$4.92M 0.01%
157,386
+23,821
+18% +$703K
ALRM icon
1261
Alarm.com
ALRM
$2.76B
$4.92M 0.01%
114,481
+7,462
+7% +$336K
FG
1262
DELISTED
FGL Holdings Ordinary Shares
FG
$4.9M 0.01%
460,266
+230,476
+100% +$2.1M
PRFT
1263
DELISTED
Perficient Inc
PRFT
$4.9M 0.01%
106,379
+5,046
+5% +$206K
AM icon
1264
Antero Midstream
AM
$10.1B
$4.9M 0.01%
645,477
+61,723
+11% +$390K
MRTX
1265
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.89M 0.01%
37,970
+2,465
+7% +$238K
NPO icon
1266
Enpro
NPO
$7.04B
$4.88M 0.01%
73,042
+4,183
+6% +$278K
TCO
1267
DELISTED
Taubman Centers Inc.
TCO
$4.88M 0.01%
157,098
+1,031
+0.7% +$35.4K
IJR icon
1268
iShares Core S&P Small-Cap ETF
IJR
$113B
$4.88M 0.01%
58,142
+23,917
+70% +$1.92M
CSOD
1269
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$4.88M 0.01%
83,269
+6,528
+9% +$378K
EAT icon
1270
Brinker International
EAT
$9.65B
$4.87M 0.01%
115,857
-3,813
-3% -$164K
STMP
1271
DELISTED
Stamps.com, Inc.
STMP
$4.84M 0.01%
57,941
+3,091
+6% +$258K
AVTR icon
1272
Avantor
AVTR
$9.18B
$4.83M 0.01%
266,309
+78,529
+42% +$1.25M
IPAR icon
1273
Interparfums
IPAR
$4.05B
$4.82M 0.01%
66,297
+3,005
+5% +$219K
ENV
1274
DELISTED
ENVESTNET, INC.
ENV
$4.81M 0.01%
69,139
+4,255
+7% +$277K
THRM icon
1275
Gentherm
THRM
$1.28B
$4.79M 0.01%
107,902
+4,686
+5% +$200K

Similar funds

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.